Fairfax County Redevelopment & Housing Authority, VA Series 2004 Bonds Rating Raised To 'AA+'; Outlook Negative Dec 11

  • ID: 2033274
  • December 2011
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) Dec. 15, 2011--Standard & Poor's Ratings Services raised its long-term rating on Fairfax County Redevelopment & Housing Authority , Va.'s (Island Walk Project) FHA-insured multifamily housing revenue bonds series 2004 to 'AA+' from 'BB+'. The outlook is negative. "The rating upgrade is based on our view of the project's reliance on short-term market rate investments," said Standard & Poor's credit analyst Renee J. Berson. The rating reflects our view of the following: The high credit quality of the FHA-insured mortgage loan collateral, which we consider to be 'AA+' eligible; Extremely strong debt service coverage; Investments held in Natixis Funding (A+/A-1), which is guaranteed by Caisse Des Depots (AAA/A-1+); and Asset/liability ratio is 103.00% as of...

Companies mentioned in this report are: Fairfax Cnty Redev & Hsg Auth
Action: Outlook: Negative
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Fairfax Cnty Redev & Hsg Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.